glp-1 agonist and dpp-4 inhibitor Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD GLP-1-based therapies, including GLP-1, GLP-1R
Description
These drugs can run hundreds to over a thousand dollars per month without insurance coverage
Analysis of donor pancreata defines the transcriptomic signature and microenvironment of early neoplastic lesions
Poly-agonists : Drugs combining GLP-1 with other hormones (GIP, glucagon, amylin) to potentially increase weight loss
doi: 10.1038/nrendo.2009.48
Every peptide in the GLP-1 family works by binding to specific receptors on cells throughout the body
